Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Low Duration Global Government Bond UCITS ETF 12.10.2026 FGOV LN IE00BKS2X200   69,469.00 GBP   1,019,746.29   17.368  ...

NEW DELHI, India & ST. PETERSBURG, Fla.--(BUSINESS WIRE)--Adani Enterprises Limited (AEL), the flagship company of the Adani Group, and Jabil Inc. (NYSE: JBL), a global engineering, supply chain and manufacturing company, have signed a non-binding Memorandum of Understanding (MoU) setting out the framework for a proposed 50:50 joint venture to manufacture and assemble artificial intelligence (AI) and data center equipment in India. The proposed joint venture remains subject to execution of defi...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - November 12.10.2026 GNOV LN IE000OJ31JQ4 850,002.00 USD 32,350,550.60 38.059  ...

CUPERTINO, Calif.--(BUSINESS WIRE)--Frontier labs push the boundary of what is possible. An Applied AI Lab closes the distance between that boundary and the results the business needs....

RYE, N.Y.--(BUSINESS WIRE)--Acadia Realty Trust (NYSE:AKR) (“Acadia” or the “Company”) will release its third quarter 2026 earnings before market on Monday, November 2, 2026. Management will conduct a conference call the same day at 11:00 AM ET to review the Company’s earnings and operating results. Participant registration and webcast information is listed below. Live Conference Call: Date:   Monday, November 2, 2026   Time:   11:00 AM ET   Participant Call:   Third Quarter 2026 Dial-In   Part...

TORONTO--(BUSINESS WIRE)--Genesys Capital Announces Second Close of Genesys University Seed Fund, Welcoming Sunnybrook and UHN as Hospital Partners....

PHILADELPHIA--(BUSINESS WIRE)--Enigma Networks®, the pioneer of Zero Trust for Internal Networks (ZTNX), today announced continued customer momentum as organizations confront a rapidly changing cybersecurity environment driven by AI-assisted attacks, autonomous agents, and increasingly sophisticated threats that appear as normal system activity. Recent milestones include the addition of Clutch Health as a customer, the renewal of YPrime, and a new customer agreement with a U.S. healthcare manuf...

DENVER--(BUSINESS WIRE)--Bootstrap Revenue Lifecycle Management System software provider SAASTEPS, announces Patent Allowance notification for their Patent Application....

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Ameresco to Announce Third Quarter 2026 Financial Results on November 9, 2026...

LARKSPUR, Calif.--(BUSINESS WIRE)--Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through development of its lead immune-activating antibody therapeutic imneskibart (AU-007), today announced that new Phase 2 data for imneskibart with avelumab in checkpoint inhibitor (CPI)-refractory adenocarcinoma non-small cell lung cancer (NSCLC) will be presented at the European Society for Medical Oncology (ESMO) Congress 2026. The congress is being held October 23-27, 202...